Diclofenac Sodium Price Trend

Diclofenac Sodium Prices June 2023

The price of diclofenac sodium in the USA for Q2 2023 reached 14941 USD/MT in June. On the other hand, the price of diclofenac sodium in China was 14141 USD/MT. In Germany, the prices for diclofenac sodium were 14879 USD/MT in the second quarter of 2023.

Diclofenac Sodium Price Trend, Market Analysis, and News

IMARC’s newly published report, titled “Diclofenac Sodium Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data,” offers an in-depth analysis of diclofenac sodium pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.

It encompasses an in-depth review of spot price of diclofenac sodium at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of diclofenac sodium price trend across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.

The report examines the elements influencing diclofenac sodium price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.

Diclofenac Sodium Market Analysis

The global diclofenac sodium market size reached US$ 2 Million in 2023. By 2032, IMARC Group expects the market to reach US$ 3 Million, at a projected CAGR of 4.90% during 2023-2032.

• The increasing occurrence of chronic pain and arthritis among the masses is driving the need for efficient treatment choices. Diclofenac sodium is a strong nonsteroidal anti-inflammatory drug (NSAID), which is very successful at treating these conditions by decreasing pain, inflammation, and joint stiffness. The United Nations Population Fund's India Ageing Report 2023 predicts that by 2050, the population over the age of 60 will increase to 20.8% or 34.7 crore. More people are suffering from degenerative joint diseases, such as osteoarthritis and inflammatory conditions, like rheumatoid arthritis with the growing aging population and increasing life expectancy. As per the Australian Institute of Health and Welfare, in the year 2023 the total disease burden for rheumatoid arthritis was 2.0%, and the total disease burden for all musculoskeletal diseases was 16%. This demographic shift is driving the demand for available and effective treatments especially for relief from pain. Diclofenac sodium is a favored treatment by the prescribers and patients alike due to its efficacy and availability in various presentations like oral formulations, topical gels, and injections. Its importance in managing arthritis symptoms makes it vital in the pharmaceutical sector for treating chronic pain.
• Advancements in formulation technologies are resulting in the development of enhanced topical remedies, patches, and extended-release tablets that provide improved pain management and higher levels of patient adherence in comparison to conventional options. These new formulations reduce the side effects on the stomach related to NSAIDs and, at the same time, provide long-lasting pain relief, which is especially important for persistent diseases. The better effectiveness and safety characteristics of the novel formulations is resulting in the increase of the patient populations for such treatments that are relatively easier to tolerate and use.
• The increase in the availability of over-the-counter (OTC) diclofenac sodium formulations is improving access to a broader range of users. In 2023, the OTC medicine industry was valued at US$ 168.7 billion. IMARC Group projects that the market will increase at a compound annual growth rate (CAGR) of 5.5% from 2024 to 2032, reaching US$ 275.9 billion in 2032. Regulatory agencies in various countries are approving the certification of these OTC, making it simpler for individuals to obtain effective pain relief for issues like sprains, strains, and minor injuries without needing a prescription from a doctor. This increased availability enables people to promptly and easily control their pain by directly purchasing from pharmacies and retail stores.

Diclofenac Sodium News

The report covers the latest developments, updates, and trends impacting the global diclofenac sodium market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in diclofenac sodium production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the diclofenac sodium price trend.

Latest developments in the diclofenac sodium industry:

• February 2023: Aurolife Pharma LLC., a subsidiary of Aurobindo Pharma, obtained official approval from the USFDA to produce and sell Diclofenac Sodium Topical Solution USP, 2% w/w, which is equivalent to Pennsaid. This marks the initial approval for Aurolife Unit-II in North Carolina, adding to Aurobindo's overall count of 430 ANDA approvals from the USFDA.
• June 2023: Zydus Lifesciences received USFDA approval to manufacture and market Diclofenac Sodium and Misoprostol Delayed-Release Tablets. These tablets, combining an NSAID and a protective agent, are employed to treat osteoarthritis and rheumatoid arthritis in patients at high risk for stomach or intestinal ulcers.

Product Description

Diclofenac sodium is a nonsteroidal anti-inflammatory drug (NSAID) that lowers inflammation and acts as a pain reliever in conditions, such as arthritis or acute injuries. It works by blocking cyclooxygenase (COX)-1 and COX-2 enzymes that help to develop prostaglandins, which results in inflammation. It is created by a complex synthesis method that includes the condensation of phenylacetic acid derivatives. It can be found in diverse formats, such as oral tablets, topical gels, and injections, which allow adaptable usage based on the specific requirements of the patient and the severity of their condition. It offers immediate pain relief to control acute pain and elevate the quality of life. It notably reduces swelling and inflammation, therefore relieving swollen joints and local tissues. It can lead to a reduction in the dependency of other medications, like opioids, which have a higher likelihood of side effects and addiction.

Regional Coverage

The report provides a detailed analysis of the diclofenac sodium market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the diclofenac sodium price trend.

Global Diclofenac Sodium Price

The report offers a holistic view of the global diclofenac sodium pricing trends in the form of diclofenac sodium price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights current price of diclofenac sodium but also provides insights into historical price trends, enabling stakeholders to understand past fluctuations and their underlying causes.

The report also delves into price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed diclofenac sodium demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing

Europe Diclofenac Sodium Price

European diclofenac sodium prices are examined, highlighting the market-specific influences in the region, such as stringent environmental regulations, the competitive landscape, and import-export imbalances that significantly affect pricing structures.

This analysis can be extended to include detailed diclofenac sodium price information for a comprehensive list of countries.

North America Diclofenac Sodium Price

The analysis of diclofenac sodium prices in North America delves into the regional industry dynamics, encompassing the impact of local production capacities and the trade flows between North America and other significant global markets.

Specific diclofenac sodium historical data within the United States and Canada can also be provided.

Middle East and Africa Diclofenac Sodium Price

The report explores the diclofenac sodium pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

In addition to region-wise data, information on diclofenac sodium prices for countries can also be provided.

Asia Pacific Diclofenac Sodium Price

The diclofenac sodium pricing trends in Asia Pacific are examined, reflecting the role of the region as a major global production hub and consumer market, with price dynamics heavily influenced by supply chain efficiencies, regional demand surges, and policy shifts in major economies.

This diclofenac sodium price analysis can be expanded to include a comprehensive list of countries within the region.

Latin America Diclofenac Sodium Price

The analysis of diclofenac sodium prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.

This comprehensive review can be extended to include specific countries within the region.

Report Coverage

Key Benefits for Stakeholders:

• IMARC’s report presents a detailed analysis of diclofenac sodium pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
• The study examines factors affecting diclofenac sodium price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
• The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
• IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The diclofenac sodium price charts ensure our clients remain at the forefront of the industry.